BUMEX Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Bumex, and when can generic versions of Bumex launch?

Bumex is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in BUMEX is bumetanide. There are six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Bumex

A generic version of BUMEX was approved as bumetanide by SAGENT on January 27^th, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for BUMEX?
What are the global sales for BUMEX?
What is Average Wholesale Price for BUMEX?

Summary for BUMEX

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	116
Patent Applications:	5,059
What excipients (inactive ingredients) are in BUMEX?	BUMEX excipients list
DailyMed Link:	BUMEX at DailyMed

Drug patent expirations by year for BUMEX

Pharmacology for BUMEX

Drug Class	Loop Diuretic
Physiological Effect	Increased Diuresis at Loop of Henle

US Patents and Regulatory Information for BUMEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BUMEX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Sign Up	⤷ Sign Up
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for BUMEX

See the table below for patents covering BUMEX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	S4913899		⤷ Sign Up
Germany	1966878	3-BUTYLAMINO-4-PHENOXY-5-SULFAMYLBENZOESAEURE UND DEREN DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE ENTHALTENDE MITTEL	⤷ Sign Up
Sweden	380013		⤷ Sign Up
Japan	S5420483		⤷ Sign Up
Japan	S5024299		⤷ Sign Up
France	2177786		⤷ Sign Up
Italy	1143801	PROCEDIMENTO PER LA PREPARAZIONE DI DERIVATI DELL'ACIDO SULFAMIL BENZOICO	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for BUMEX

Pharmacology for BUMEX

Make Better Decisions: Try a trial or see plans & pricing